Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

Published:2011-01 Issue:1 Volume:50 Page:65-74
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Fineman Mark,Flanagan Shawn,Taylor Kristin,Aisporna Maria,Shen Larry Z.,Mace Kenneth F.,Walsh Brandon,Diamant Michaela,Cirincione Brenda,Kothare Prajakti,Li Wen-I,MacConell Leigh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

2. Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes

3. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

4. Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porous Silicon Microparticles Enable Sustained Release of GLP‐1R Agonist Peptides for the Treatment of Type 2 Diabetes;Advanced Therapeutics;2024-08-10

2. The role of partial area under the curve and maximum concentrations in assessing the bioequivalence of long-acting injectable formulation of exenatide_A sensitivity analysis;European Journal of Pharmaceutical Sciences;2024-04

3. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Chronic GLP1 therapy reduces postprandial IL6 in obese humans with prediabetes;Cardiovascular Endocrinology & Metabolism;2024-01-04

5. An Extended Minimal Model of OGTT: Estimation of Alpha- and Beta-Cell Dysfunction, Insulin Resistance, and the Incretin Effect;American Journal of Physiology-Endocrinology and Metabolism;2023-12-13